Profiling Gut Microbiome and Metabolites Aids Diagnosis and Prediction of Progression in Mild Cognitive Impairment.

Zhang B, Brown R, Bayer A, Waring J, Morgan BP, Marchesi JR, Zhou Y

Open source

DOI
10.1002/mco2.71045
Published
2026 Oct
Container
MedComm
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mco2.71045,
  title = {Profiling Gut Microbiome and Metabolites Aids Diagnosis and Prediction of Progression in Mild Cognitive Impairment.},
  author = {Zhang B and Brown R and Bayer A and Waring J and Morgan BP and Marchesi JR and Zhou Y},
  year = {2026},
  journal = {MedComm},
  doi = {10.1002/mco2.71045},
  url = {https://doi.org/10.1002/mco2.71045}
}

RIS

TY  - JOUR
TI  - Profiling Gut Microbiome and Metabolites Aids Diagnosis and Prediction of Progression in Mild Cognitive Impairment.
AU  - Zhang B
AU  - Brown R
AU  - Bayer A
AU  - Waring J
AU  - Morgan BP
AU  - Marchesi JR
AU  - Zhou Y
PY  - 2026
JO  - MedComm
DO  - 10.1002/mco2.71045
UR  - https://doi.org/10.1002/mco2.71045
ER  - 

APA

B, Z., R, B., A, B., J, W., BP, M., JR, M., & Y, Z. (2026). Profiling Gut Microbiome and Metabolites Aids Diagnosis and Prediction of Progression in Mild Cognitive Impairment.. MedComm. https://doi.org/10.1002/mco2.71045

Source records